CRAX2MACE模型在意大利疑似冠心病行负荷心肌灌注显像患者队列中的外部验证
在1003例疑似冠心病行负荷-静息单光子发射计算机断层心肌灌注显像的患者中外部验证CRAX2MACE模型。模型预测2年主要不良心脏事件的受试者工作特征曲线下面积为0.612,Brier评分为0.061,Hosmer-Lemeshow检验示拟合不佳(χ2=28,P<.001)。仅硬事件时曲线下面积0.621、Brier评分0.053,拟合仍差(χ2=31,P<.001)。结论认为该模型预测价值有限。
要点
- CRAX2MACE模型外部验证的受试者工作特征曲线下面积为0.612,区分能力有限。
- Hosmer-Lemeshow检验示模型拟合不佳(χ2=28,P<.001)。
- 仅硬事件时曲线下面积0.621,拟合仍差(χ2=31,P<.001)。
核心结论
- CRAX2MACE模型在疑似冠心病患者外部验证队列中对2年主要不良心血管事件的预测价值有限。
研究设计与样本
- 纳入2015年3月至2019年4月在本学术中心行负荷-静息单光子发射计算机断层心肌灌注显像的1003例疑似冠心病患者,对CRAX2MACE模型进行外部验证。
主要发现
- 以主要不良心脏事件(全因死亡、急性心肌梗死或晚期冠状动脉血运重建)为终点,CRAX2MACE模型的受试者工作特征曲线下面积为0.612,Brier评分为0.061。
- Hosmer-Lemeshow检验估计拟合不佳(χ2=28,P<.001)。
- 仅以硬事件(心源性死亡、急性心肌梗死)为终点,CRAX2MACE模型外部验证的Brier评分为0.053,受试者工作特征曲线下面积为0.621。
- 按十分位计算的Hosmer-Lemeshow检验显示拟合差(χ2=31,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prevention and development of diagnostic and therapeutic techniques reduced morbidity and mortality for coronary artery disease (CAD). In this context, the cardiovascular risk assessment for major adverse cardiac events (MACE) at 2-year (CRAX2MACE) model for prediction of 2-year major adverse cardiac events was developed. We performed an external validation of this model. METHODS: We included 1003 patients with suspected CAD undergoing stress-rest single-photon emission computed tomography myocardial perfusion imaging at our academic center between March 2015 and April 2019. RESULTS: Considering the occurrence of MACE (death from any cause, acute myocardial infarction, or late coronary revascularization), for the CRAX2MACE model the area under the receiver operating characteristic curve was 0.612 and the Brier score was 0.061. The Hosmer-Lemeshow test estimated a non-optimal fit (χ2 28, P < .001). Considering only hard events (cardiac death, acute myocardial infarction), the external validation of the CRAX2MACE model revealed a Brier score of 0.053 and an area under the receiver operating characteristic curve of 0.621. Hosmer-Lemeshow test was calculated by deciles and showed a poor fit (χ2 31, P < .001). CONCLUSION: CRAX2MACE model had a limited value for predicting 2-year major adverse cardiovascular events in an external validation cohort of patients with suspected CAD.
引用
- Megna R, Petretta M, Assante R, et al. External validation of the CRAX2MACE model in an Italian cohort of patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging. J Nucl Cardiol. 2021. PMID: 34734366. doi:10.1007/s12350-021-02855-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。